Inicio>>FFA3 agonist 1

FFA3 agonist 1

Catalog No.GC70773

FFA3 agonist 1 es un agonista del receptor de ácidos grasos libres 3 (FFA3).

Products are for research use only. Not for human use. We do not sell to patients.

FFA3 agonist 1 Chemical Structure

Cas No.: 886358-51-6

Tamaño Precio Disponibilidad Cantidad
5 mg
21,00 $
Disponible
10 mg
32,00 $
Disponible
25 mg
69,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
FFA3 agonist 1 is an agonist of free fatty acid receptor 3 (FFA3). FFA3 agonist 1 regulates the health effect of intestinal microbiota by activating FFA3.

FFA3 agonist 1 (0.01-100 µM) increases the incorporation of [35S]GTPgS and the generation of pERK1/2, reduces the production of cAMP in Flp-In T-REx 293 cells that induced the expression of enhanced yellow fluorescent protein (eYFP) human free fatty acid receptor 3 (hFFA3)[2].
FFA3 agonist 1 (0.1-100 µM) increases the incorporation of [35S]GTPgS in Flp-In T-REx 293 cells induced to express hFFA3, mouse FFA3 (mFFA3) and rat FFA3 (rFFA3)[2].

References:
[1]. Ulven ER, et al. Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators. J Med Chem. 2020 Apr 9;63(7):3577-3595.
[2]. Hudson BD, Christiansen E, Murdoch H, Jenkins L, Hansen AH, Madsen O, Ulven T, Milligan G. Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands. Mol Pharmacol. 2014 Aug;86(2):200-10.

Reseñas

Review for FFA3 agonist 1

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FFA3 agonist 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.